Perelman School of Medicine at the University of Pennsylvania
test_header

The Department of Radiation Oncology is in the new Perelman Center. Occupying approximately 80,000 square feet on the Concourse Level, the new treatment facilities includes the most advanced proton and conventional radiation treatment modalities available as well as public spaces designed for the highest levels of patient comfort.


2nd Annual Dept. of Radiation Oncology Research Retreat

PRESENTER

PRESENTATION TITLE

Yee (Kao)

“Compliance with national vaccination guidelines in patients receiving radiation therapy”

BarAd

“Gabapentin for the treatment of pain related to RT-induced mucositisin patients with head and neck Ca treated with (IMRT)”

Christensen 

”Aggressive supportive care improves outcomes in the combined modality treatment of pancreatic & duodenal cancer”

Busch lab

“O2-conserving PDT at high fluence rate through modulation of photosensitizer dose”

Dolinsky 

“Improved rate of sphincter sparing surgery following preop chemo-RT for rectal cancer with (5FU/OX) vs (5-FU) alone”

Nemani (Lin)

“Prognostic factors and adjuvant therapy in patients with uterine carcinosarcoma”

McDonough

“New technical developments in Proton Therapy”

Kennedy lab

“Cancer prevention and space radiation”

Hill

“Hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma: A tale of two techniques”

Du

“IMRT for the treatment of malignant mesothelioma”

Blackstock

“Translational Research: Unique Challenges in Radiation Oncology”

Koumenis Lab

“Targeting RT & hypoxia resistance w/ existing and novel compnds”

Finlay

“Photon dose calculation analysis of a Varian Tx planning system algorithm on a Siemens linear accelerator”

Das

“Dosimetric comparison of High-Z inhomogeneity in IMRT: A collaborative study”

Dutta

“Association between esophageal stricture formation & (DVH) parameters in oropharyngeal cancer pts treated with (IMRT)

Cengel

“Survival signaling through nuclear EGFR and STAT3 mediates PDT Resistance in ovarian and lung cancer cells”

Dutta

“Timing & disclosure of complementary & alternative medical practices (CAM) in patients receiving radiation therapy”

D. Bruner

“RTOG 0215: Tx of erectile dysfxn in prostate Ca pts treated with neoadjuvant & concurrent androgen deprivation & RT"

Zhu

“Macroscopic modeling of the singlet oxygen during PDT”

Maity

“Inhibition of PI3K/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation”

Kao Lab

“Pharmaco-genetic modulation of the DNA damage response”

Plastaras

“Stage-specific survival benefit of post-operative radiation therapy for cancers of the rectosigmoid junction”

Rajendran

“Valproic acid as an established histone deacetylase inhibitor for radiosensitizing androgen-independent prostate cancer cells”



© The Trustees of the University of Pennsylvania || Site best viewed in a supported browser. || Site Design: PMACS Web Team